S Garner

1.4k total citations
14 papers, 309 citations indexed

About

S Garner is a scholar working on Economics and Econometrics, Automotive Engineering and Dermatology. According to data from OpenAlex, S Garner has authored 14 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Economics and Econometrics, 2 papers in Automotive Engineering and 2 papers in Dermatology. Recurrent topics in S Garner's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmaceutical Economics and Policy (4 papers) and Additive Manufacturing Materials and Processes (2 papers). S Garner is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmaceutical Economics and Policy (4 papers) and Additive Manufacturing Materials and Processes (2 papers). S Garner collaborates with scholars based in United Kingdom, United States and Canada. S Garner's co-authors include Stephen R. Thom, Harry Ischiropoulos, D. L. Fisher, S. Tsuyoshi Ohnishi, Michael F. Beers, Nemesha Desai, Ser‐Ling Chua, Vincent Piguet, Pick N Woo and Anthony D. Ormerod and has published in prestigious journals such as Journal of Clinical Investigation, Clinical Pharmacology & Therapeutics and British Journal of Dermatology.

In The Last Decade

S Garner

12 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Garner United Kingdom 7 91 58 58 51 46 14 309
Eva Vets United States 7 58 0.6× 84 1.4× 37 0.6× 36 0.7× 7 0.2× 10 349
Péter Takács Hungary 12 75 0.8× 27 0.5× 48 0.8× 11 0.2× 71 1.5× 23 480
Juan Carlos Obaya Spain 9 63 0.7× 99 1.7× 101 1.7× 7 0.1× 9 0.2× 45 480
Paul Novotny United States 8 57 0.6× 22 0.4× 58 1.0× 12 0.2× 19 0.4× 17 572
Mario Monti Sweden 12 95 1.0× 39 0.7× 105 1.8× 11 0.2× 51 1.1× 31 391
Paweł Kiciński Poland 11 64 0.7× 26 0.4× 67 1.2× 18 0.4× 4 0.1× 30 354
Juan Pablo Álzate Colombia 9 33 0.4× 25 0.4× 83 1.4× 4 0.1× 71 1.5× 30 303
Jelena Stevanović Netherlands 12 101 1.1× 39 0.7× 89 1.5× 3 0.1× 46 1.0× 39 429
Bob G. Schultz United States 7 50 0.5× 89 1.5× 75 1.3× 6 0.1× 12 0.3× 28 350
M. Charokopou United Kingdom 11 69 0.8× 80 1.4× 78 1.3× 15 0.3× 40 0.9× 38 400

Countries citing papers authored by S Garner

Since Specialization
Citations

This map shows the geographic impact of S Garner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Garner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Garner more than expected).

Fields of papers citing papers by S Garner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Garner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Garner. The network helps show where S Garner may publish in the future.

Co-authorship network of co-authors of S Garner

This figure shows the co-authorship network connecting the top 25 collaborators of S Garner. A scholar is included among the top collaborators of S Garner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Garner. S Garner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Nguyen, Dinh-Son, S Garner, & Albert C. To. (2025). A test artifact for rapid evaluation of material ductility variation in laser powder bed fusion. Additive manufacturing. 109. 104878–104878.
2.
Garner, S, et al.. (2024). Enhancing the Graduate Nursing Student Experience Through Gamification. Nursing Education Perspectives. 47(2). 121–123. 1 indexed citations
3.
Dong, Wen, et al.. (2024). Data-driven distortion compensation for laser powder bed fusion process using Gaussian process regression and inherent strain method. Materials & Design. 243. 113063–113063. 2 indexed citations
4.
Tichelaar, Jelle, et al.. (2020). WHO guide to good prescribing is 25 years old: quo vadis?. European Journal of Clinical Pharmacology. 76(4). 507–513. 21 indexed citations
5.
Makady, Amr, Bettina Ryll, Keith R. Abrams, et al.. (2017). Practicalities Of Using Real-World Evidence (RWE) In Comparative Effectiveness Research (CER): Learnings From Imi-Getreal. Value in Health. 20(9). A692–A692.
6.
Jónsson, Páll, et al.. (2016). A Framework To Guide The Use Of Real-World Evidence To Support Evaluation Of Relative Effectiveness Of New Medicines. Value in Health. 19(7). A488–A488. 2 indexed citations
7.
Ingram, John R, Pick N Woo, Ser‐Ling Chua, et al.. (2016). Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality. British Journal of Dermatology. 174(5). 970–978. 52 indexed citations
8.
Hirsch, Gigi, Mark Trusheim, M Bala, et al.. (2016). Adaptive Biomedical Innovation: Evolving Our Global System to Sustainably and Safely Bring New Medicines to Patients in Need. Clinical Pharmacology & Therapeutics. 100(6). 685–698. 9 indexed citations
9.
Schneeweiß, Sebastian, Anna García‐Altés, S Garner, et al.. (2016). Real World Data in Adaptive Biomedical Innovation: A Framework for Generating Evidence Fit for Decision‐Making. Clinical Pharmacology & Therapeutics. 100(6). 633–646. 44 indexed citations
10.
Bouvy, Jacoline C., et al.. (2016). Health Technology Assessment in the Context of Adaptive Pathways for Medicines in Europe: Challenges and Opportunities. Clinical Pharmacology & Therapeutics. 100(6). 594–597. 9 indexed citations
11.
12.
Rosso, J.Q. Del & S Garner. (2011). Commentaries on ‘Minocycline for acne vulgaris: efficacy and safety’ with a response from the review authors. Evidence-Based Child Health A Cochrane Review Journal. 6(5). 1547–1549. 1 indexed citations
13.
Garner, S, et al.. (2002). Rofecoxib for rheumatoid arthritis. The Cochrane Database of Systematic Reviews. CD003685–CD003685. 25 indexed citations
14.
Ischiropoulos, Harry, Michael F. Beers, S. Tsuyoshi Ohnishi, et al.. (1996). Nitric oxide production and perivascular nitration in brain after carbon monoxide poisoning in the rat.. Journal of Clinical Investigation. 97(10). 2260–2267. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva Vets Breakdown of academic impact, for papers by Péter Takács Breakdown of academic impact, for papers by Juan Carlos Obaya Breakdown of academic impact, for papers by Paul Novotny Breakdown of academic impact, for papers by Mario Monti Breakdown of academic impact, for papers by Paweł Kiciński Breakdown of academic impact, for papers by Juan Pablo Álzate Breakdown of academic impact, for papers by Jelena Stevanović Breakdown of academic impact, for papers by Bob G. Schultz Breakdown of academic impact, for papers by M. Charokopou
Rankless by CCL
2026